{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:28:10Z","timestamp":1776371290650,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,24]]},"DOI":"10.7759\/cureus.17407","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T12:18:34Z","timestamp":1629807514000},"source":"Crossref","is-referenced-by-count":12,"title":["Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature"],"prefix":"10.7759","author":[{"given":"Sujan","family":"Poudel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Quinonez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinal","family":"Choudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary T","family":"Au","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Paesani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armond K","family":"Thiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Ruxmohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mobashir","family":"Hosameddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo F","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05800-7","article-title":"Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population","volume":"35","author":"Azcarate PM","year":"2020","unstructured":"Azcarate PM, Zhang AJ, Keyhani S, Steigerwald S, Ishida JH, Cohen BE. Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population. J Gen Intern Med. 2020, 35:1979-86. 10.1007\/s11606-020-05800-7","journal-title":"J Gen Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/head.13345","article-title":"Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science","volume":"58","author":"Baron EP","year":"2018","unstructured":"Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science. Headache. 2018, 58:1139-86. 10.1111\/head.13345","journal-title":"Headache"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1206738","article-title":"Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells","volume":"81","author":"Giudice ED","year":"2007","unstructured":"Giudice ED, Rinaldi L, Passarotto M, et al.. Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells. J Leukoc Biol. 2007, 81:1512-22. 10.1189\/jlb.1206738","journal-title":"J Leukoc Biol"},{"key":"ref4","article-title":"Cannabis and neuropsychiatric disorders: an updated review","volume":"28(2)","author":"Chayasirisobhon S","year":"2019","unstructured":"Chayasirisobhon S. Cannabis and neuropsychiatric disorders: an updated review. Acta Neurol Taiwan. 2019, 28(2):27-39.","journal-title":"Acta Neurol Taiwan"},{"key":"ref5","article-title":"Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"29","author":"Russo EB","year":"2008","unstructured":"Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?. Neuro Endocrinol Lett. 2008, 29:192-200.","journal-title":"Neuro Endocrinol Lett"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1987.hed2708442.x","article-title":"Marijuana and migraine","volume":"27","author":"el-Mallakh RS","year":"1987","unstructured":"el-Mallakh RS. Marijuana and migraine. Headache. 1987, 27:442-3. 10.1111\/j.1526-4610.1987.hed2708442.x","journal-title":"Headache"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00172","article-title":"Endocannabinoid system and migraine pain: an update","volume":"12","author":"Greco R","year":"2018","unstructured":"Greco R, Demartini C, Zanaboni AM, Piomelli D, Tassorelli C. Endocannabinoid system and migraine pain: an update. Front Neurosci. 2018, 12:172. 10.3389\/fnins.2018.00172","journal-title":"Front Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/19390211.2020.1769246","article-title":"Practical considerations of hypotheses and evidence in cannabis pharmacotherapy: refining expectations of clinical endocannabinoid deficiency","volume":"17","author":"Cogan PS","year":"2020","unstructured":"Cogan PS. Practical considerations of hypotheses and evidence in cannabis pharmacotherapy: refining expectations of clinical endocannabinoid deficiency. J Diet Suppl. 2020, 17:608-24. 10.1080\/19390211.2020.1769246","journal-title":"J Diet Suppl"},{"key":"ref9","unstructured":"State medical marijuana laws. (2021). Accessed. August 3, 2021: https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1188\/17.CJON.409","article-title":"Cannabis guidelines","volume":"21","author":"Kennedy Sheldon L","year":"2017","unstructured":"Kennedy Sheldon L. Cannabis guidelines. Clin J Oncol Nurs. 2017, 21:409. 10.1188\/17.CJON.409","journal-title":"Clin J Oncol Nurs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.633168","article-title":"Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain","volume":"12","author":"MacCallum CA","year":"2021","unstructured":"MacCallum CA, Eadie L, Barr AM, Boivin M, Lu S. Practical strategies using medical cannabis to reduce harms associated with long term opioid use in chronic pain. Front Pharmacol. 2021, 12:633168. 10.3389\/fphar.2021.633168","journal-title":"Front Pharmacol"},{"key":"ref12","unstructured":"Compassionate Medical Cannabis Act of 2014. (2014). Accessed. August 8, 2021: https:\/\/www.flsenate.gov\/Session\/Bill\/2014\/1030."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.4\/nkogan","article-title":"Cannabinoids in health and disease","volume":"9","author":"Kogan NM","year":"2007","unstructured":"Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci. 2007, 9:413-30. 10.31887\/DCNS.2007.9.4\/nkogan","journal-title":"Dialogues Clin Neurosci"},{"key":"ref14","article-title":"Medical cannabis: do the benefits outweigh the risks?","volume":"17","author":"Gupta S","year":"2018","unstructured":"Gupta S, Phalen T, Gupta S. Medical cannabis: do the benefits outweigh the risks?. Current Psychiatry. 2018, 17:34-41.","journal-title":"Current Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy6040128","article-title":"Weighing the benefits and risks of medical marijuana use: a brief review","volume":"6","author":"Karst A","year":"2018","unstructured":"Karst A. Weighing the benefits and risks of medical marijuana use: a brief review. Pharmacy (Basel). 2018, 6:128. 10.3390\/pharmacy6040128","journal-title":"Pharmacy (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01344.x","article-title":"Cluster attacks responsive to recreational cannabis and dronabinol","volume":"49","author":"Robbins MS","year":"2009","unstructured":"Robbins MS, Tarshish S, Solomon S, Grosberg BM. Cluster attacks responsive to recreational cannabis and dronabinol. Headache. 2009, 49:914-6. 10.1111\/j.1526-4610.2009.01344.x","journal-title":"Headache"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060360","article-title":"Migraine frequency decrease following prolonged medical cannabis treatment: a cross-sectional study","volume":"10","author":"Aviram J","year":"2020","unstructured":"Aviram J, Vysotski Y, Berman P, Lewitus GM, Eisenberg E, Meiri D. Migraine frequency decrease following prolonged medical cannabis treatment: a cross-sectional study. Brain Sci. 2020, 10:360.","journal-title":"Brain Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0186-6","article-title":"Psychoactive substances as a last resort - a qualitative study of self-treatment of migraine and cluster headaches","volume":"14","author":"Andersson M","year":"2017","unstructured":"Andersson M, Persson M, Kjellgren A. Psychoactive substances as a last resort - a qualitative study of self-treatment of migraine and cluster headaches. Harm Reduct J. 2017, 14:60. 10.1186\/s12954-017-0186-6","journal-title":"Harm Reduct J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2019.11.001","article-title":"Short- and long-term effects of cannabis on headache and migraine","volume":"21","author":"Cuttler C","year":"2020","unstructured":"Cuttler C, Spradlin A, Cleveland MJ, Craft RM. Short- and long-term effects of cannabis on headache and migraine. J Pain. 2020, 21:722-30. 10.1016\/j.jpain.2019.11.001","journal-title":"J Pain"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0862-2","article-title":"Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort","volume":"19","author":"Baron EP","year":"2018","unstructured":"Baron EP, Lucas P, Eades J, Hogue O. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. J Headache Pain. 2018, 19:37. 10.1186\/s10194-018-0862-2","journal-title":"J Headache Pain"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1673","article-title":"Effects of medical cannabis on migraine headache frequency in an adult population","volume":"36","author":"Rhyne DN","year":"2016","unstructured":"Rhyne DN, Anderson SL, Gedde M, Borgelt LM. Effects of medical cannabis on migraine headache frequency in an adult population. Pharmacotherapy. 2016, 36:505-10. 10.1002\/phar.1673","journal-title":"Pharmacotherapy"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412468669","article-title":"Use of cannabis among 139 cluster headache sufferers","volume":"33","author":"Leroux E","year":"2013","unstructured":"Leroux E, Taifas I, Valade D, Donnet A, Chagnon M, Ducros A. Use of cannabis among 139 cluster headache sufferers. Cephalalgia. 2013, 33:208-13. 10.1177\/0333102412468669","journal-title":"Cephalalgia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/082585970201800207","article-title":"Medical efficacy of cannabinoids and cannabis: a comprehensive review of the literature","volume":"18","author":"Bagshaw SM","year":"2002","unstructured":"Bagshaw SM, Hagen NA. Medical efficacy of cannabinoids and cannabis: a comprehensive review of the literature. J Palliat Care. 2002, 18:111-22. 10.1177\/082585970201800207","journal-title":"J Palliat Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0490-1","article-title":"Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial","volume":"13","author":"Pini LA","year":"2012","unstructured":"Pini LA, Guerzoni S, Cainazzo MM, et al.. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. J Headache Pain. 2012, 13:677-84. 10.1007\/s10194-012-0490-1","journal-title":"J Headache Pain"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3959(98)00033-5","article-title":"Cannabis for migraine treatment: the once and future prescription? An historical and scientific review","volume":"76","author":"Russo E","year":"1998","unstructured":"Russo E. Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain. 1998, 76:3-8. 10.1016\/s0304-3959(98)00033-5","journal-title":"Pain"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2000.10400245","article-title":"Who is using cannabis as a medicine and why: an exploratory study","volume":"32","author":"Ogborne AC","year":"2000","unstructured":"Ogborne AC, Smart RG, Weber T, Birchmore-Timney C. Who is using cannabis as a medicine and why: an exploratory study. J Psychoactive Drugs. 2000, 32:435-43. 10.1080\/02791072.2000.10400245","journal-title":"J Psychoactive Drugs"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.26828\/cannabis.2019.01.005","article-title":"Medical cannabis use among adults in the Southeastern United States","volume":"2","author":"Salazar CA","year":"2019","unstructured":"Salazar CA, Tomko RL, Akbar SA, Squeglia LM, McClure EA. Medical cannabis use among adults in the Southeastern United States. Cannabis. 2019, 2:53-65.","journal-title":"Cannabis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.joim.2020.07.004","article-title":"Alleviative effects of Cannabis flower on migraine and headache","volume":"18","author":"Stith SS","year":"2020","unstructured":"Stith SS, Diviant JP, Brockelman F, Keeling K, Hall B, Lucern S, Vigil JM. Alleviative effects of Cannabis flower on migraine and headache. J Integr Med. 2020, 18:416-24. 10.1016\/j.joim.2020.07.004","journal-title":"J Integr Med"},{"key":"ref29","unstructured":"Review of the 3rd European Academy of Neurology Congress 2017. (2017). Accessed. August 3, 2021: https:\/\/www.emjreviews.com\/neurology\/congress-review\/review-of-the-3rd-european-academy-of-neurology-congress-2017\/."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2019.05.009","article-title":"Cannabis use preferences and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain","volume":"20","author":"Boehnke KF","year":"2019","unstructured":"Boehnke KF, Scott JR, Litinas E, Sisley S, Clauw DJ, Goesling J, Williams DA. Cannabis use preferences and decision-making among a cross-sectional cohort of medical cannabis patients with chronic pain. J Pain. 2019, 20:1362-72. 10.1016\/j.jpain.2019.05.009","journal-title":"J Pain"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117699616","article-title":"Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep","volume":"31","author":"Piper BJ","year":"2017","unstructured":"Piper BJ, DeKeuster RM, Beals ML, et al.. Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. J Psychopharmacol. 2017, 31:569-75. 10.1177\/0269881117699616","journal-title":"J Psychopharmacol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton M","year":"2016","unstructured":"Sexton M, Cuttler C, Finnell JS, Mischley LK. A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy. Cannabis Cannabinoid Res. 2016, 1:131-8. 10.1089\/can.2016.0007","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01416-9","article-title":"Cannabis use in hospitalized patients with chronic pain","volume":"37","author":"Orhurhu V","year":"2020","unstructured":"Orhurhu V, Urits I, Olusunmade M, et al.. Cannabis use in hospitalized patients with chronic pain. Adv Ther. 2020, 37:3571-83. 10.1007\/s12325-020-01416-9","journal-title":"Adv Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2202\/1941-2851.1017","article-title":"An analysis of applicants presenting to a medical marijuana specialty practice in California","volume":"4","author":"Nunberg H","year":"2011","unstructured":"Nunberg H, Kilmer B, Pacula RL, Burgdorf J. An analysis of applicants presenting to a medical marijuana specialty practice in California. J Drug Policy Anal. 2011, 4:10.2202\/1941-2851.1017","journal-title":"J Drug Policy Anal"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67643-medical-cannabis-headaches-and-migraines-a-review-of-the-current-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:55Z","timestamp":1707506995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67643-medical-cannabis-headaches-and-migraines-a-review-of-the-current-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.17407","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}